Skip to main content

Advertising Disclaimer »

Main menu

  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • AAP Policy
    • Topic/Program Collections
    • Policy
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effect on Pediatric Health
    • More Collections...
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Alerts
    • Table of Contents
    • Insights
  • AAP Career Center
  • Subscribe
  • Other Publications
    • American Academy of Pediatrics

User menu

  • Log in

Search

  • Advanced search
American Academy of Pediatrics

AAP Gateway

Advanced Search

AAP Logo

  • Log in
  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • AAP Policy
    • Topic/Program Collections
    • Policy
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effect on Pediatric Health
    • More Collections...
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Alerts
    • Table of Contents
    • Insights
  • AAP Career Center
  • Subscribe

Blood test may offer new way to detect concussions

Carla Kemp , Senior Editor
December 04, 2015
Elevated levels of a protein in the serum of children with blunt head trauma were associated with intracranial lesions on computed tomography (CT) scan, according to a study of 152 youths from birth to age 21 years.

Efforts are being made to reduce head CT scans in children with traumatic brain injury (TBI) due to risks from radiation exposure. As a result, researchers are looking for alternative ways to diagnose concussions.

Studies in adults have shown that glial fibrillary acidic protein (GFAP) may be a biomarker for TBI. GFAP is found in glial cells, which surround neurons in the brain. The protein is released into serum within an hour of TBI.

Linda Papa, M.D., M.Sc., an emergency medicine physician and researcher at Orlando Health, led a team that conducted a prospective controlled study to determine if GFAP was significantly elevated in the serum of youths with mild or moderate TBI compared with youths who suffered trauma that didn’t affect the head. They also looked at the association between GFAP levels and intracranial lesions on CT scan.

The results are published in the report “Performance of Glial Fibrillary Acidic Protein in Detecting Traumatic Intracranial Lesions on Computed Tomography in Children and Youth With Mild Head Injury” (Papa L, et al. Acad Emerg Med. 2015;22:1274-1282, http://onlinelibrary.wiley.com/doi/10.1111/acem.12795/abstract).

“We have so many diagnostic blood tests for different parts of the body, like the heart, liver and kidneys, but there’s never been a reliable blood test to identify trauma in the brain,” Dr. Papa said in a news release. “We think this test could change that.”

Subjects included patients who presented to three Level 1 trauma centers after head injury. They had Glasgow Coma Scale (GCS) scores of 9 to 15. Trauma patients without head injury served as controls and had GCS scores of 15 and normal mental status.

Blood samples were obtained from all subjects within six hours of injury, and serum GFAP levels were measured.

CT scans were performed in 152 patients with head trauma. Eleven percent had intracranial lesions, and all had GCS scores of 13 to 15. Serum levels of GFAP were significantly higher in those with intracranial lesions than those without lesions (1.01 vs. 0.18 nanograms/milliliter). The blood test had a sensitivity of 94%, a specificity of 47% and a negative predictive value of 98% for detecting intracranial lesions. The findings were similar for children of all ages.

“This simple blood test was nearly as accurate as a state-of-the-art CT scan,” Dr. Papa said.

In addition, the median levels of GFAP increased incrementally from trauma controls (0.03 ng/mL) to those who had head trauma without TBI symptoms (0.09 ng/mL) to patients with head trauma and TBI symptoms (0.15 ng/mL) to those with intracranial lesions (1.01 ng/mL).

The authors noted that because blood samples were drawn within six hours of injury, they were unable to determine the accuracy of the test outside this window.

Researchers said in the news release that they plan to continue studying the blood test and hope it will be available commercially in the next five years.


Resources
  • Information for parents on concussions
  • AAP policy "Tackling in Youth Football"
  • Follow AAP News on Facebook.
  • Follow AAP News on Twitter.
Copyright © 2015, The American Academy of Pediatrics

Advertising Disclaimer »

Download PDF
Email News Article

Thank you for your interest in spreading the word on American Academy of Pediatrics.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Blood test may offer new way to detect concussions
(Your Name) has sent you a message from American Academy of Pediatrics
(Your Name) thought you would like to see the American Academy of Pediatrics web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Blood test may offer new way to detect concussions
Carla Kemp
December 04, 2015
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
  • Digital Edition Current Issue
  • Latest Daily News
  • Archives
  • Collections
  • Columns
  • Advertising
  • Subscribe to AAP News Magazine
  • Terms of Use
  • Privacy Statement
  • FAQ
  • Contact Us
  • 2021 AAP Journals Catalog
  • Pediatrics
  • Pediatrics in Review
  • Hospital Pediatrics
  • NeoReviews
  • AAP Grand Rounds
  • AAP Career Center
  • shopAAP
  • AAP.org
  • AAP News
  • Visit AAP News on Facebook
  • Follow AAP News on Twitter
American Academy of Pediatrics

© 2021 American Academy of Pediatrics